Niche Leadership Target Spine Surgeons and hospitals focusing on minimally invasive fusion procedures, highlighting Kleiner Device Labs’ KG1 and KG2 Surge systems as proven tools that reduce complication risk, improve graft delivery, and potentially lower overall procedure costs.

Innovative Portfolio Position the company’s broad patent portfolio and ongoing product runway as a selling point for health systems seeking differentiated, patent-protected instruments that support both MIS and open surgical techniques.

Awarded Validation Leverage recent recognition from Medical Design Excellence Awards to build credibility with procurement teams and value-based care committees as evidence of market-leading design and clinical impact.

Strategic Partnerships Explore collaboration opportunities with distributors, hospital networks, and imaging/orthopedic device groups to scale adoption of KG1 and KG2 Surge, especially in facilities investing in cost containment and workflow efficiency.

Growth Readiness Highlight the company’s growth trajectory, investor interest, and scalable manufacturing potential to attract strategic investors and channel partners who can accelerate market penetration in mid-market and regional IDN settings.